Raymond James & Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.8M | Buy |
162,074
+26,657
| +20% | +$1.78M | 0.01% | 1178 |
|
|
2024
Q2 | $16.1M | Sell |
135,417
-23,627
| -15% | -$2.81M | 0.01% | 888 |
|
|
2024
Q1 | $16.9M | Buy |
159,044
+4,602
| +3% | +$490K | 0.01% | 850 |
|
|
2023
Q4 | $15.4M | Sell |
154,442
-31,900
| -17% | -$3.17M | 0.01% | 851 |
|
|
2023
Q3 | $19.2M | Buy |
186,342
+31,423
| +20% | +$3.25M | 0.02% | 694 |
|
|
2023
Q2 | $18.8M | Buy |
154,919
+7,562
| +5% | +$919K | 0.02% | 722 |
|
|
2023
Q1 | $22.6M | Sell |
147,357
-21,134
| -13% | -$3.25M | 0.02% | 630 |
|
|
2022
Q4 | $30.3M | Buy |
168,491
+11,663
| +7% | +$2.09M | 0.03% | 496 |
|
|
2022
Q3 | $18.5M | Sell |
156,828
-56,302
| -26% | -$6.66M | 0.02% | 639 |
|
|
2022
Q2 | $30.4M | Buy |
213,130
+19,144
| +10% | +$2.73M | 0.03% | 458 |
|
|
2022
Q1 | $33.4M | Buy |
193,986
+21,143
| +12% | +$3.64M | 0.03% | 482 |
|
|
2021
Q4 | $43.9M | Buy |
172,843
+24,622
| +17% | +$6.25M | 0.04% | 426 |
|
|
2021
Q3 | $57M | Buy |
148,221
+1,105
| +0.8% | +$425K | 0.05% | 314 |
|
|
2021
Q2 | $34.6M | Buy |
147,116
+7,069
| +5% | +$1.66M | 0.03% | 463 |
|
|
2021
Q1 | $18.3M | Buy |
140,047
+49,381
| +54% | +$6.47M | 0.02% | 710 |
|
|
2020
Q4 | $9.47M | Buy |
90,666
+16,940
| +23% | +$1.77M | 0.01% | 987 |
|
|
2020
Q3 | $5.22M | Sell |
73,726
-40,660
| -36% | -$2.88M | 0.01% | 1196 |
|
|
2020
Q2 | $7.35M | Buy |
114,386
+85,597
| +297% | +$5.5M | 0.01% | 979 |
|
|
2020
Q1 | $862K | Buy |
28,789
+17,721
| +160% | +$531K | ﹤0.01% | 2079 |
|
|
2019
Q4 | $216K | Sell |
11,068
-2,174
| -16% | -$42.4K | ﹤0.01% | 3275 |
|
|
2019
Q3 | $211K | Buy |
13,242
+1,503
| +13% | +$23.9K | ﹤0.01% | 3202 |
|
|
2019
Q2 | $172K | Sell |
11,739
-3,231
| -22% | -$47.3K | ﹤0.01% | 3284 |
|
|
2019
Q1 | $305K | Buy |
+14,970
| New | +$305K | ﹤0.01% | 2957 |
|